epigallocatechin gallate has been researched along with Hormone-Dependent Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmad, KA; Ahmed, K; Harris, NH; Johnson, AD; Lindvall, HC; Wang, G | 1 |
| Weinstein, B | 1 |
1 review(s) available for epigallocatechin gallate and Hormone-Dependent Neoplasms
| Article | Year |
|---|---|
Relevance of the concept of oncogene addiction to hormonal carcinogenesis and molecular targeting in cancer prevention and therapy.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Catechin; Female; Humans; Male; Neoplasms, Hormone-Dependent; Oncogenes; Prostatic Neoplasms; Sulindac | 2008 |
1 other study(ies) available for epigallocatechin gallate and Hormone-Dependent Neoplasms
| Article | Year |
|---|---|
Protein kinase CK2 modulates apoptosis induced by resveratrol and epigallocatechin-3-gallate in prostate cancer cells.
Topics: Apoptosis; Casein Kinase II; Caspase 3; Catechin; Cell Proliferation; Drug Therapy, Combination; Humans; Immunoblotting; Male; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Resveratrol; Signal Transduction; Stilbenes; TNF-Related Apoptosis-Inducing Ligand; Tumor Cells, Cultured | 2007 |